Cite
Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.
MLA
Yap, Celene Y. L., et al. “Intravenous Midazolam-Droperidol Combination, Droperidol or Olanzapine Monotherapy for Methamphetamine-Related Acute Agitation: Subgroup Analysis of a Randomized Controlled Trial.” Addiction, vol. 112, no. 7, July 2017, pp. 1262–69. EBSCOhost, https://doi.org/10.1111/add.13780.
APA
Yap, C. Y. L., Taylor, D. M., Knott, J. C., Taylor, S. E., Phillips, G. A., Karro, J., Chan, E. W., Kong, D. C. M., & Castle, D. J. (2017). Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial. Addiction, 112(7), 1262–1269. https://doi.org/10.1111/add.13780
Chicago
Yap, Celene Y. L., David McD Taylor, Jonathan C. Knott, Simone E. Taylor, Georgina A. Phillips, Jonathan Karro, Esther W. Chan, David C. M. Kong, and David J. Castle. 2017. “Intravenous Midazolam-Droperidol Combination, Droperidol or Olanzapine Monotherapy for Methamphetamine-Related Acute Agitation: Subgroup Analysis of a Randomized Controlled Trial.” Addiction 112 (7): 1262–69. doi:10.1111/add.13780.